Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

LeukoSite and Oxford Asymmetry collaboration in IBD

Oct. 4, 1996

Promising phase III results with treatment for ulcerative colitis

Oct. 4, 1996

Clinical trial on oral H. pylori vaccine completed

Oct. 4, 1996

GI drugs under development at Takeda

Sep. 27, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Generic dicyclomine HCl now available in the U.S.

Sep. 27, 1996

Clinical trials with Gilead Sciences' GS-840

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...